145 related articles for article (PubMed ID: 38369634)
1. ATP6AP1 as a potential prognostic biomarker in CRC by comprehensive analysis and verification.
Zhang S; Wang Y; Zhang X; Wang M; Wu H; Tao Y; Fan W; Liu L; Wang B; Gao W
Sci Rep; 2024 Feb; 14(1):4018. PubMed ID: 38369634
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and immunological value of
Wang J; Liu Y; Zhang S
Aging (Albany NY); 2021 Jul; 13(13):16904-16921. PubMed ID: 34228637
[TBL] [Abstract][Full Text] [Related]
3. The impact of SLC10A3 on prognosis and immune microenvironment in colorectal adenocarcinoma.
Wang B; Fan W; Tao Y; Zhang S; Wang J; Fan Z; Liu L; Wang Y
Eur J Med Res; 2024 Jan; 29(1):20. PubMed ID: 38178258
[TBL] [Abstract][Full Text] [Related]
4. Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer.
Zhu C; Wang S; Du Y; Dai Y; Huai Q; Li X; Du Y; Dai H; Yuan W; Yin S; Wang H
BMC Gastroenterol; 2022 Oct; 22(1):437. PubMed ID: 36253721
[TBL] [Abstract][Full Text] [Related]
5. F-Box and Leucine-Rich Repeat Protein 7 Is a Prognostic Biomarker and Is Correlated with the Immunosuppressive Microenvironment in Colorectal Cancer.
Wang S; Zhao X; Zhu S; Xu J; Luo T
Genet Test Mol Biomarkers; 2023 Oct; 27(10):325-338. PubMed ID: 37862037
[No Abstract] [Full Text] [Related]
6. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
[TBL] [Abstract][Full Text] [Related]
7. Collagen synthase P4HA3 as a novel biomarker for colorectal cancer correlates with prognosis and immune infiltration.
Guo X; Zhang Y; Peng L; Wang Y; He CW; Li K; Hao K; Li K; Wang Z; Huang H; Miao X
Heliyon; 2024 Jun; 10(11):e31695. PubMed ID: 38832271
[TBL] [Abstract][Full Text] [Related]
8. MTUS1 is a promising diagnostic and prognostic biomarker for colorectal cancer.
Cheng LY; Huang MS; Zhong HG; Ru HM; Mo SS; Wei CY; Su ZJ; Mo XW; Yan LH; Tang WZ
World J Surg Oncol; 2022 Aug; 20(1):257. PubMed ID: 35962436
[TBL] [Abstract][Full Text] [Related]
9. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
[No Abstract] [Full Text] [Related]
10. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
11. ATP6AP1 is a potential prognostic biomarker and is associated with iron metabolism in breast cancer.
Tian Y; Gao M; Huang L; Zhou H; Wang J
Front Genet; 2022; 13():958290. PubMed ID: 36147483
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
[TBL] [Abstract][Full Text] [Related]
13. Interferon regulatory factor family influences tumor immunity and prognosis of patients with colorectal cancer.
Chen YJ; Luo SN; Dong L; Liu TT; Shen XZ; Zhang NP; Liang L
J Transl Med; 2021 Sep; 19(1):379. PubMed ID: 34488791
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Pattern Provides a New Scoring System and Predicts the Prognosis and Immune Therapeutic Response in Glioma.
Jiang F; Lu DF; Zhan Z; Yuan GQ; Liu GJ; Gu JY; Sun XO; Wang Z
Cells; 2022 Dec; 11(24):. PubMed ID: 36552760
[TBL] [Abstract][Full Text] [Related]
15. Integrated Profiling Identifies
Shi J; Bao M; Wang W; Wu X; Li Y; Zhao C; Liu W
Front Immunol; 2021; 12():722807. PubMed ID: 34646265
[TBL] [Abstract][Full Text] [Related]
16. SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal Cancer.
Zhang HP; Wu J; Liu ZF; Gao JW; Li SY
Biomed Res Int; 2022; 2022():1398268. PubMed ID: 35111844
[TBL] [Abstract][Full Text] [Related]
17. Mapk14 is a Prognostic Biomarker and Correlates with the Clinicopathological Features and Immune Infiltration of Colorectal Cancer.
Wang D; Peng L; Hua L; Li J; Liu Y; Zhou Y
Front Cell Dev Biol; 2022; 10():817800. PubMed ID: 35141222
[No Abstract] [Full Text] [Related]
18. Identification and validation of immunotherapy for four novel clusters of colorectal cancer based on the tumor microenvironment.
Zheng X; Ma Y; Bai Y; Huang T; Lv X; Deng J; Wang Z; Lian W; Tong Y; Zhang X; Yue M; Zhang Y; Li L; Peng M
Front Immunol; 2022; 13():984480. PubMed ID: 36389763
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
Front Immunol; 2022; 13():951455. PubMed ID: 36189298
[TBL] [Abstract][Full Text] [Related]
20. An immune-related gene prognostic index for predicting prognosis in patients with colorectal cancer.
Li C; Wirth U; Schardey J; Ehrlich-Treuenstätt VV; Bazhin AV; Werner J; Kühn F
Front Immunol; 2023; 14():1156488. PubMed ID: 37483596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]